The mechanisms of fluoroquinolone resistance in two isolates of Enterobacter cloacae, Ecl#1 and Ecl#2, from the same patient and with identical pulsed-field gel electrophoresis patterns, have been analysed. MICs of ciprofloxacin were 0.25 and 1 mg/L for Ecl#1 and Ecl#2, respectively. Ecl#2 was also more resistant to chloramphenicol and organic solvents. The quinolone resistance determining regions of gyrA/B and parC/E, and the marORA and acrB genes, were sequenced. Expression of marR, acrB, soxS, robA, ramA and fis was analysed by northern blotting. The activity of a 90 bp E. cloacae mar promoter fragment was examined with the reporter plasmid pIGJ-1mar. Sequencing the gyrAB and parCE genes revealed a single amino acid substitution in GyrA (corresponding to position 83 in GyrA of Escherichia coli) in Ecl#1 and Ecl#2 (Phe83) compared with reference strain E. cloacae DSMZ 3264 (Thr83). Ecl#2 accumulated significantly less norfloxacin and displayed higher levels of expression of marR and acrB than Exl#1, indicative of greater fluoroquinolone efflux activity. Sequencing gyrB, parC/E and marORA, and northern blotting of robA, ramA and fis, did not reveal any further differences between the two strains. No homologue of soxRS was detected in E. cloacae. Expression of GFP from pIGJ1-mar in Ecl#2 was higher than in Ecl#1. In these two closely related clinical isolates of E. cloacae, a target mutation in GyrA (Ecl#1 and Ecl#2) and increased fluoroquinolone efflux by AcrAB (Ecl#2) contribute to the resistance phenotypes, corroborating findings in vitro and in vivo about the sequential development of fluoroquinolone resistance.
Introduction
Based on data obtained in vitro, it has been proposed that the development of fluoroquinolone resistance in Escherichia coli is due to progressive accumulation of target alterations in GyrA, mutations that increase active efflux, and target alterations in ParC. 1 It is not clear whether this combination of specific and non-specific resistance mechanisms is peculiar to this E. coli K12 strain, to E. coli in general or to the situation in vitro. We have shown that, in E. coli, overexpression of the AcrAB efflux pump system increases fluoroquinolone resistance over and above that conferred by target mutations in GyrA and ParC. 2 The natural role of the AcrAB efflux pump system may be to confer resistance to substances hazardous to the bacteria, including such structurally diverse compounds as fluoroquinolones, tetracyclines, chloramphenicol, organic solvents, oxidative stress agents and the disinfectant triclosan, many of which may be environmental. [3] [4] [5] In E. coli, expression of AcrAB is regulated negatively by its repressor AcrR and positively by the transcription factors MarA and SoxS. 6 As in a signal cascade, production of MarA is regulated by various positive and negative transcription factors, specifically MarR, 7 MarA, 8 SoxS, 6 RobA 9 and Ram, 10 and the accessory factor Fis, 9 as demonstrated in studies with E. coli and Klebsiella pneumoniae. In the present study, we analysed the resistance mechanisms of two closely related clinical isolates of Enterobacter cloacae with reduced susceptibility to ciprofloxacin (CIP), chloramphenicol (CAT), doxycycline (DOX) and organic solvents. 
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Increase in
PFGE
A rapid pulsed-field gel electrophoresis (PFGE) procedure was carried out as described previously. 12 Chromosomal DNA was digested with SpeI at 37ЊC for 3 h. Electrophoresis was carried out with the CHEF-mapper system (BioRad, Hercules, CA, USA). The run time was 14 h, with an initial switch time of 2.16 s and a final switch time of 35 s.
Susceptibility testing
MICs of CIP, CAT and DOX were determined by Etest (AB Biodisk, Solna, Sweden). To test organic solvent tolerance, isolates were inoculated on to Mueller-Hinton agar at a concentration of 10 5 cfu/spot and the agar surface was overlaid with hexane and cyclohexane to generate different levels of organic solvent toxicity. Hexane and cyclohexane have distribution coefficients in octanol/water of 3.9 and 3.4, respectively. 13 The plates were checked for visible bacterial growth after 2 days incubation at 37ЊC.
DNA amplification and nucleotide sequence determination
Primers and PCR conditions for amplification of partial regions of the gyrA, gyrB, parC, parE, marRA, acrB, soxS, robA, fis, yjcC, yjcD and ram genes are listed in Table 1 . Complementary strands were sequenced in duplicate using PCR primers (6 pmol) on a 310 DNA sequencer (PerkinElmer, Foster City, CA, USA).
In contrast to all other target genes, we were unable to amplify a sox homologue using various sets of primers specific for the E. coli gene under low-stringency conditions. An attempt was made to amplify soxRS from adjacent gene loci, assuming similar gene arrangements in E. coli and E. cloacae. Using E. coli specific primers for yicC and yicD, a PCR product of the expected size was recovered using E. cloacae genomic DNA as template; however, when sequenced, no sequences or open reading frames homologous to the soxRS genes of E. coli were detected by BLAST search.
RNA extraction and northern blot analysis
Overnight cultures were diluted 100-fold in LB broth and grown with shaking to mid-logarithmic phase at 37ЊC. Paraquat (45 min, final concentration 1.3 mM; Sigma, Deisenhofen, Germany) was added to induce the sox operon or its equivalent. Digoxigenin-labelled probes were obtained by PCR. RNA was purified with the RNeasy Purification Kit (Qiagen, Hilden, Germany). Northern blotting was carried out using standard techniques, 14 with glyceraldehyde phosphate dehydrogenase specific probes for control.
Complementation assays
For complementation tests, the marR wild-type gene of E. coli under the control of the bla promoter was introduced into Ecl#1 and Ecl#2 by mobilization, using the filter mating technique. 15 The donor strain E. coli S17 containing plasmid pBP591 and the recipient strain, Ecl#1 or Ecl#2, were mixed in a 1:1 ratio and incubated at 37ЊC for 12 h on minimal agar. Cells were scraped from the surface of the agar, suspended in LB broth and plated on LB agar containing kanamycin 50 mg/L for selection.
Accumulation of norfloxacin
Accumulation of norfloxacin (NOR) was determined according to Martínez-Martínez et al. 16 to demonstrate active efflux mechanism(s). Bacteria were incubated with NOR (10 mg/L, 10 min) in the absence and presence of carbonyl cyanide m-chlorophenylhydrazone (CCCP, 0.1 mM). Fluorescence (proportional to the concentration of NOR) was determined on a Hitachi F 2000 fluorescence spectrophotometer (Hitachi, Tokyo, Japan; excitation 279 nm, emission 445 nm).
Promoter studies PCR fragments of 252, 96 and 30 bp of marO of Ecl#1 immediately upstream of the transcription start of marR were cloned in-frame into the pUC18-derived reporter plasmid pIGJ containing the CAT and GFP genes using a BglII restriction site (Figure 2a) . Plasmids pIGJ-1mar (252 bp), pIGJ-4mar (96 bp) and pIGJ-5mar (30 bp) were introduced into Ecl#1 and Ecl#2, and the expression of GFP was determined by fluorescence-activated cell sorting Table 1 
GenBank accession numbers
GenBank accession numbers of E. cloacae genes are listed in Table 1 .
Data analysis
SPSS 8.0 for Windows was used for calculation of the Mann-Whitney U-test results.
Results and discussion
Two isolates of E. cloacae (Ecl#1 and Ecl#2) were recovered from two infection sites (conjunctivitis and peritonitis) in the same patient. The isolates showed identical PFGE patterns (data not shown) and 100% identity in all gene sequences obtained in the course of the study. Thus, the isolates can be considered to be genetically and epidemiologically closely related. From our data, we cannot decide whether fluoroquinolone resistance in the two isolates evolved independently or sequentially. Ecl#1 and Ecl#2 display different CIP MICs of 0.25 and 1 mg/L, respectively, and Ecl#2 is more resistant to organic solvents, DOX and CAT ( Elevated MICs of the structurally unrelated antibiotics CAT and DOX, together with the increase in organic solvent tolerance displayed by Ecl#2 compared with Ecl#1, are consistent with an efflux phenotype. The role of an efflux mechanism in quinolone resistance of Ecl#2 was confirmed by its significantly lower NOR accumulation (P Ͻ 0.001). The metabolic uncoupler CCCP increased NOR accumulation in both strains; however, accumulation by Ecl#2 was affected more. Consistent with these findings, increased expression of marR and acrB in Ecl#2, compared with Ecl#1 and DSMZ 3264, was demonstrated by northern blotting (Figure 1 ). To investigate further the regulation of marRA expression in the E. cloacae strains and to evaluate the possible role of marOR, the promoter regions (marO) and the repressor genes (marR) of Ecl#1 and Ecl#2 were sequenced. The corresponding sequences in both strains were found to be identical. Both showed differences in MarR, compared with DSMZ 3264, at residue 6 (Tyr instead of Ile) and residue 80 (Val instead of Ala). Complementation of Ecl#2 with the marR wild-type sequence of E. coli had no effect on the MIC of CIP.
The transcription factors SoxS, 6 Ram 10 and RobA 9 and the accessory factor Fis 9 also act on the mar operon. However, northern blotting of robA, fis and ram detected lowlevel expression of these genes in both strains, with no apparent differences (data not shown).
In contrast to all other target genes, we were unable to identify a sox homologue by PCR using several sets of primers specific for the E. coli genes, under low-stringency conditions or by northern blotting with different probes. Although these results do not necessarily rule out the presence of a sox homologue in DSMZ 3264, Ecl#1 and Ecl#2, our results argue against it.
The hypothesis that the presence or absence of an unknown factor influences expression of the mar locus in Ecl#2 was challenged by the introduction of reporter plasmids into Ecl#1 and Ecl#2. When plasmids pIGJ-1mar What is the basic level of activity of efflux pumps of Enterobacteriaceae under natural circumstances in the host? 21 Our findings of constitutive overexpression of MarR (which is cotranscribed with MarA) in Ecl#2 in the present study and of MarA in E. coli 2 indicate that physiological regulation of the AcrAB locus does not generate sufficient efflux pump activity under conditions in vivo. Two observations indicate that the constitutive overexpression of MarRA in Ecl#2 does not influence the biological fitness of the bacterium. First, the isolate was grown from a site of infection 6 days after the last dose of CIP and therefore has to be regarded as fully pathogenic. Second, growth curves (obtained by recording optical density over time until stationary growth; data not shown) of the two isolates Ecl#1 and Ecl#2 revealed no apparent difference compared with those of three other clinical wild-type E. cloacae isolates.
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In conclusion, in this pair of closely related clinical isolates of E. cloacae, different levels of quinolone resistance can be explained by increased AcrAB efflux pump activity in the more resistant strain, in addition to a target mutation in GyrA in both strains. These data corroborate findings in vitro 1 and in vivo 2 concerning the sequential development of fluoroquinolone resistance. 
